Licenses drugs to uniQure, Teva and Genentech for LPLD, pain and acne.
Industry: Health Care
First Day Return: +16.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/10/2014 |
Offer Price | $9.00 |
Price Range $10.00 - $12.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/04/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Burnaby, Canada |
Founded | 1996 |
Employees at IPO | 74 |
Website www.xenon-pharma.com |